Le Lézard
Classified in: Health
Subjects: HSP, AVO

March of Dimes Statement on Marijuana Use in Pregnancy

ARLINGTON, Va., Aug. 29, 2019 /PRNewswire/ -- March of Dimes today released the following statement from Rahul Gupta, MD, MPH, MBA, FACP, Chief Medical & Health Officer, Senior Vice President, in response to the release of the U.S. Surgeon General's Advisory: Marijuana Use and the Developing Brain

March of Dimes Foundation Logo (PRNewsfoto/March of Dimes Foundation)

"March of Dimes applauds today's release of the US Surgeon General's Advisory on the dangers of marijuana use during pregnancy for both mom and baby. The evidence clearly shows that no amount of marijuana has been proven safe to use during pregnancy or while breastfeeding. Unfortunately, this message is not resonating with all expecting women and maternity care providers, and marijuana use among pregnant women has doubled between 2002 and 2017.

"According to data from the National Survey on Drug Use and Health, cannabis use in pregnant women has more than doubled over the past 15 years, from 3.4 percent to 7 percent, and use is more common during the first trimester of pregnancy. A National Institute on Drug Abuse study found cannabis use during pregnancy has been associated with effects on fetal growth, including low birth weight and length, and these outcomes may be more likely among women who consume marijuana frequently during pregnancy, especially in the first and second trimesters.

"Today's advisory and its associated digital campaign are critical to raising awareness among the public about the detrimental impact exposure to elta-9-tetrahydrocannabinol (THC) has on an infant's developing brain in utero. March of Dimes also applauds the Department of Health and Human Services' commitment to accelerating research on the health effects of marijuana, and encourages the Department to prioritize pregnant women and their infants in that research.

"March of Dimes encourages women who are pregnant and considering using marijuana to treat the side effects of pregnancy to consult with their health care provider to identify treatments that are safer for both mom and baby. Further, pregnant women struggling with substance use disorders should seek assistance from their health care provider to begin appropriate treatment."

March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs and provide education and advocacy so that every baby can have the best possible start. Building on a successful 80-year legacy of impact and innovation, we empower every mom and every family. Visit marchofdimes.org or nacersano.org for more information. Visit shareyourstory.org for comfort and support. Find us on Facebook and follow us on Instagram and Twitter.


SOURCE March of Dimes

These press releases may also interest you

at 17:50
Amphivena Therapeutics, Inc., a private clinical stage immuno-oncology company developing T cell engager therapeutics for cancer, presented today at the American Society of Hematology annual meeting data from a Phase 1 study of its bivalent T cell...

at 17:40
Welltower Inc. announces that on December 24, 2019, it is redeeming all of the outstanding 3.35% Senior Notes due November 25, 2020 (the "Notes") issued by HCN Canadian Holdings-1 LP, its wholly-owned subsidiary, in accordance with the terms of the...

at 17:20
Quest Diagnostics Incorporated , the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal amount of its 2.950% senior notes due 2030 under the Quest...

at 17:20
Bariatric Surgery Devices (General Surgery) - Global Market Analysis and Forecast Model Read the full report: https://www.reportlinker.com/p05830908/?utm_source=PRN Summary Bariatric Surgery Devices (General Surgery) - Global Market Analysis and...

at 17:19
Florida International University Distinguished Professor Madhavan Nair has been named a Fellow of the National Academy of Inventors (NAI). Nair, an internationally renowned expert in nanotechnology and HIV research, is the founding chair of the...

at 17:05
TFF Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced its third quarter 2019...

News published on 29 august 2019 at 16:49 and distributed by: